Sionna Therapeutics, Inc. Common Stock (SION) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 38.50
(+186.67%)
Based on the Sionna Therapeutics, Inc. Common Stock stock forecast from 2 analysts, the average analyst target price for Sionna Therapeutics, Inc. Common Stock is USD 38.50 over the next 12 months. Sionna Therapeutics, Inc. Common Stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Sionna Therapeutics, Inc. Common Stock is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Sionna Therapeutics, Inc. Common Stock’s stock price was USD 13.43. Sionna Therapeutics, Inc. Common Stock’s stock price has changed by +9.01% over the past week, +21.32% over the past month and 0% over the last year.
No recent analyst target price found for Sionna Therapeutics, Inc. Common Stock
No recent average analyst rating found for Sionna Therapeutics, Inc. Common Stock
Company Overview Sionna Therapeutics, Inc. Common Stock
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cystic fibrosis (CF). It develops nucleotide-binding domain 1 (NBD1) stabilizers that normalize CFTR function for CF patients; Galicaftor (SION-2222) and SION-2851; SION-109, an ICL4-directed CFTR corrector; and Navocaftor (SION-3067), a potentiator. Sionna Therapeutics, Inc. formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. The company was incorporated in 2019 and is based in Waltham, Massachusetts. Read Less
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cystic fibrosis (CF). It develops nucleotide-binding domain 1 (NBD1) stabilizers that normalize CFTR function for CF patients; Galicaftor (SION-2222) and SION-2851; SION...Read More
Frequently Asked Questions About Sionna Therapeutics, Inc. Common Stock (SION) Stock
Based on ratings from 2 analysts Sionna Therapeutics, Inc. Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on SION's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for SION is USD 38.50 over the next 12 months. The maximum analyst target price is USD 45 while the minimum anlayst target price is USD 32.
Unfortunately we do not have enough data on SION's stock to indicate if its overvalued.
The last closing price of SION's stock was USD 13.43.
Unfortunately we do not currently have any market capitalization data for SION's stock.
Based on targets from 2 analysts, the average taret price for SION is projected at USD 38.50 over the next 12 months.
This means that SION's stock price may go up by +186.67% over the next 12 months.
We can't find any ETFs which contains Sionna Therapeutics, Inc. Common Stock's stock.
As per our most recent records Sionna Therapeutics, Inc. Common Stock has 41 Employees.
Sionna Therapeutics, Inc. Common Stock's registered address is 21 Hickory Drive, Waltham, MA, United States, 02451.
You can get more information about it from Sionna Therapeutics, Inc. Common Stock's website at https://www.sionnatx.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
There is nothing we particularly dislike
Frequently Asked Questions About Sionna Therapeutics, Inc. Common Stock (SION) Stock
Based on ratings from 2 analysts Sionna Therapeutics, Inc. Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on SION's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for SION is USD 38.50 over the next 12 months. The maximum analyst target price is USD 45 while the minimum anlayst target price is USD 32.
Unfortunately we do not have enough data on SION's stock to indicate if its overvalued.
The last closing price of SION's stock was USD 13.43.
Unfortunately we do not currently have any market capitalization data for SION's stock.
Based on targets from 2 analysts, the average taret price for SION is projected at USD 38.50 over the next 12 months.
This means that SION's stock price may go up by +186.67% over the next 12 months.
We can't find any ETFs which contains Sionna Therapeutics, Inc. Common Stock's stock.
As per our most recent records Sionna Therapeutics, Inc. Common Stock has 41 Employees.
Sionna Therapeutics, Inc. Common Stock's registered address is 21 Hickory Drive, Waltham, MA, United States, 02451.
You can get more information about it from Sionna Therapeutics, Inc. Common Stock's website at https://www.sionnatx.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SION !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
